Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: Structural requirements of the central moiety for farnesyltransferase inhibitory activity

Citation
M. Schlitzer et al., Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: Structural requirements of the central moiety for farnesyltransferase inhibitory activity, BIO MED CH, 8(10), 2000, pp. 2399-2406
Citations number
21
Categorie Soggetti
Chemistry & Analysis
Journal title
BIOORGANIC & MEDICINAL CHEMISTRY
ISSN journal
09680896 → ACNP
Volume
8
Issue
10
Year of publication
2000
Pages
2399 - 2406
Database
ISI
SICI code
0968-0896(200010)8:10<2399:NNBFIP>2.0.ZU;2-8
Abstract
Recently, we have described non-peptidic, non-prenylic bisubstrate analogue s as a novel type of farnesyltransferase inhibitor composed of a farnesyl-m imetic, a linker and an AAX-peptidomimetic substructure. With this study, w e showed that the amide function connecting the farnesyl-mimetic and the li nking substructures of our inhibitors is crucial for their activity. We sug gest that the amide is bound to the essential zinc ion in the farnesyltrans ferases active center. We identified succinic and glutaric acid, respective ly, in addition to the initially used beta-alanyl moiety as suitable linkin g structures. Glycine can also be used in this function provided the distan ce between the alpha-amide group and the center of the peptidomimetic subst ructure is enlarged by introduction of an additional methylene unit into th e peptidomimetic substructure. (C) 2000 Elsevier Science Ltd. All rights re served.